The National Post has an article on shortages in the supply of about 10-15 generic drugs.
The generic drug companies point to manufacturing and supply problems - and remember that this is a global industry, so we're often talking about off-shore supply problems - but the journalists can't help wondering if this reflects the recent changes in generic drug pricing regimes.
The Five-Year IP Roadmap Is Over: How to Build an IP Strategy for a Future
You Can’t Predict
-
Long-lived patents, an AI-shifted landscape: why a fixed filing roadmap
fails, and the three decision rules an IP strategy needs instead.
6 days ago

No comments:
Post a Comment